Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.30
-0.06 (-1.12%)
Apr 15, 2026, 4:00 PM EDT - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.46 million as of April 15, 2026. Its market cap has decreased by -54.52% in one year.
Market Cap
13.46M
Enterprise Value
1.65M
1-Year Change
-54.52%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.46M, a decrease of -79.60%. That is a compound annual growth rate of -43.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 13.62M | -44.73% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 14.45M |
| IN8bio | 13.79M |
| Hoth Therapeutics | 13.33M |
| Moleculin Biotech | 13.02M |
| BioCardia | 13.02M |
| Cellectar Biosciences | 12.89M |
| Kairos Pharma | 12.85M |
| Cyclerion Therapeutics | 12.81M |